Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ZyVersa Therapeutics Inc.

    NASDAQ: ZVSA · Real-Time Price · USD
    0.31
    -0.24 (-43.53%)
    At close: Jul 16, 2025, 3:59 PM

    ZyVersa Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a 10.4K 10.4K 10.4K
    Gross Profit
    		 n/a -10.4K -10.4K -10.4K
    Operating Income
    		 -9.14B -14.42M -13.01M -7.7M
    Interest Income
    		 n/a n/a 427.54 821.37
    Pretax Income
    		 -9.42B -107.75M -14.05M -8.08M
    Net Income
    		 -9.41B -98.3M -759.1M -8.91M
    Selling & General & Admin
    		 7.36B 11.2M 7.61M 5.58M
    Research & Development
    		 1.78B 3.21M 5.41M 2.12M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 9.13M 14.41M 13.01M 7.7M
    Interest Expense
    		 269.86K -457K 427.54K 821.37K
    Selling & Marketing Expenses
    		 n/a -11.2B n/a n/a
    Cost & Expenses
    		 n/a 14.42M 13.01M 7.7M
    Income Tax Expense
    		 -6.75M -9.46M 745.05M 821.37K
    Shares Outstanding (Basic)
    		 1.11M 97.5K 25.95K 46.55K
    Shares Outstanding (Diluted)
    		 1.11M 97.5K 25.95K 46.55K
    EPS (Basic)
    		 -8.48 -1.09K -930.25 -173.66
    EPS (Diluted)
    		 -8.48 -1.09K -930.25 -173.66
    EBITDA
    		 -9.14B -107.74M -11.67M -7.25M
    EBIT
    		 -9.15B -107.75M -14.44M -7.26M
    Depreciation & Amortization
    		 n/a 10.4K 10.4K 10.4K

    Add to Watchlist